Position Statement: “the so called withdrawal reactions”

In an Expert Statement for the Science Media Centre, Professor Allan Young, King’s College London, offered this opinion in relation to the Royal College of Psychiatrists Position Statement on antidepressants and depression:

“Antidepressants, like all drugs, should be taken as per best advice. So called withdrawal reactions are usually mild to moderate and respond well to simple management. Anxiety about this should not obscure the real benefits of this type of treatment.”

The Editor-in-Chief of the BMJ, Fiona Godlee, recently said:

Professor Allan Young is a good example of the present:

Professor Allan Young  has given paid lectures and advisory boards for the following companies with drugs used in affective and related disorders: Astrazeneca, Eli Lilly, Lundbeck, Sunovion, Servier, Livanova, Janssen, Allegan, Bionomics.

Professor Allan Young is paid Consultant to Johnson & Johnson and paid Consultant to Livanova

Professor Allan Young has received honoraria for attending advisory boards and presenting talks at meetings organised by LivaNova.

Professor Allan Young is an Investigator in research for Astra Zeneca, Eli Lilly, Lundbeck, Wyeth, Janssen.

Professor Allan Young is a member, and recent Past President of, The Royal College of Psychiatrists Psychopharmacology Committee.

Professor Allan Young is President of the British Association for Psychopharmacology

2 Replies to “Position Statement: “the so called withdrawal reactions””

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.